Stem cells for research purposes; stem cells for scientific purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological tissue for research and scientific purposes; Cultures of cell media for scientific or research use; chemical reagents for use in biotechnology science research, other than for medical or veterinary use; nutritive agents for processing living cells [other than for medical use]; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology [other than for medical use]; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research use.

Cell therapeutics namely media for bacteriological culture; genetically and otherwise modified cells for medical or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; Living cells for medical use; cells for medical use; biological preparations for medical use; diagnostic preparations for medical and/or veterinary purposes, namely clinical diagnostic reagents, biomarker reagents, diagnostic chemical reagents for medical and veterinary purposes; cell preparations for drug screening; cell preparations for genetic testing, screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use; tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; cell separation reagents; dietary supplements for general health and wellbeing; dietary Protein supplements for general health and wellbeing; nutritional dietary supplements for general health and wellbeing

Pharmaceutical preparations and substances for use in gene therapy; genetic medicines and regenerative therapies for the treatment of central nervous system [CNS] diseases; pharmaceuticals and medical preparations and substances for genetically based diseases and disorders, namely, for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; medicines for human purposes, namely, for treating genetically based diseases and disorders, namely, for the treatment of central nervous system [CNS] diseases; Viral vectors for use in the delivery of gene therapy; viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for delivering genes to biological cells for use in the treatment of genetic diseases, sicknesses, and disorders.

Pharmaceutical research and development; Clinical research in the field of genetic medicine, gene therapy and regenerative medicines; Testing, inspection, research and development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; Biological information analysis, namely, genetic testing for medical research purposes; Scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; Providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease.

Architectural consultancy; architectural consultancy services; architectural design; interior design; interior design services

Soin des cheveux a l'aide de l'application de produits BIO

Huile d'olive extra vierge à usage alimentaire

Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use as stabilizing agents, active pharmaceutical ingredients, drug delivery molecules, carrier substances and buffer compounds, all for use in the development, formulation and manufacture of pharmaceuticals and biopharmaceuticals and vaccines; Silicon namely, silicon nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticles for use in industry, science and research; silicon-stabilised hybrid lipid nanoparticles for use in industry, science and research; silicon-stabilised lipid nanoparticles for use in industry, science and research; stabilised lipid nanoparticles for use in industry, science and research; nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticles for carrying and delivery of chemical, biochemical and biological substances; lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon¬ stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; lipid nanoparticles for stabilising of chemical, biochemical and biological substances; silicon-lipid nanoparticle materials for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for stabilising nucleic acids; silicon nanoparticle materials for stabilising nucleic acids; porous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticles for stabilising nucleic acids; silicon-lipid nanoparticle materials for stabilising nucleic acids; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; silicon-stabilised lipid nanoparticles for stabilising nucleic acids; nanoparticles for stabilising nucleic acid-lipid complexes; silicon nanoparticle materials for stabilising nucleic acid-lipid complexes; porous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes.

Drug delivery agents in the form of nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of porous silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of lipid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon-lipid hybrid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of nano-capsules and micro-capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; Silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; porous silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; lipid nanoparticles for medical, veterinary and pharmaceutical research purposes; silicon-lipid hybrid nanoparticles for medical, veterinary and pharmaceutical research purposes; Stabilizing agents for vaccines for humans and for animals; Stabilizing agents for nucleic acids; silicon nanoparticles for stabilizing nucleic acids, silicon nanoparticles for stabilizing nucleic acids; porous silicon nanoparticles for stabilizing nucleic acids, lipid nanoparticles for stabilizing nucleic acids, silicon-lipid hybrid nanoparticles for stabilizing nucleic acids; Stabilizing agents for nucleic acid-lipid complexes; silicon nanoparticles for stabilizing nucleic acid-lipid complexes, silicon nanoparticles for stabilizing nucleic acid-lipid complexes; porous silicon nanoparticles for stabilizing nucleic acid-lipid complexes, lipid nanoparticles for stabilizing nucleic acid-lipid complexes, silicon-lipid hybrid nanoparticles for stabilizing nucleic acid-lipid complexes; Transfection agents for nucleic acids; Silicon nanoparticles for controlled release of nucleic acids; porous silicon nanoparticles for controlled release of nucleic acids; lipid nanoparticles for controlled release of nucleic acids; silicon-lipid hybrid nanoparticles for controlled release of nucleic acids.

Non-medicated toothpaste

Providing access to online portal containing information, resources and training materials for personnel at medical treatment centers to enable the personnel to assist and manage the center's procedures in connection with patient enrollment, patient cell collection, patient infusion processes and patient cell traceability.

Decorative material in the form of artificial snow

Paperboard cartons